ENTRY       D11744                      Drug
NAME        Avalglucosidase alfa (USAN/INN);
            Avalglucosidase alfa (genetical recombination) (JAN);
            Avalglucosidase alfa-ngpt;
            Nexviazyme (TN)
PRODUCT     NEXVIAZYME (Genzyme Corporation)
FORMULA     C4490H6818N1197O1299S32
EXACT_MASS  99313.531
MOL_WEIGHT  99375.4984
SEQUENCE    QQGASRPGPR DAQAHPGRPR AVPTQCDVPP NSRFDCAPDK AITQEQCEAR GCCYIPAKQG
            LQGAQMGQPW CFFPPSYPSY KLENLSSSEM GYTATLTRTT PTFFPKDILT LRLDVMMETE
            NRLHFTIKDP ANRRYEVPLE TPRVHSRAPS PLYSVEFSEE PFGVIVHRQL DGRVLLNTTV
            APLFFADQFL QLSTSLPSQY ITGLAEHLSP LMLSTSWTRI TLWNRDLAPT PGANLYGSHP
            FYLALEDGGS AHGVFLLNSN AMDVVLQPSP ALSWRSTGGI LDVYIFLGPE PKSVVQQYLD
            VVGYPFMPPY WGLGFHLCRW GYSSTAITRQ VVENMTRAHF PLDVQWNDLD YMDSRRDFTF
            NKDGFRDFPA MVQELHQGGR RYMMIVDPAI SSSGPAGSYR PYDEGLRRGV FITNETGQPL
            IGKVWPGSTA FPDFTNPTAL AWWEDMVAEF HDQVPFDGMW IDMNEPSNFI RGSEDGCPNN
            ELENPPYVPG VVGGTLQAAT ICASSHQFLS THYNLHNLYG LTEAIASHRA LVKARGTRPF
            VISRSTFAGH GRYAGHWTGD VWSSWEQLAS SVPEILQFNL LGVPLVGADV CGFLGNTSEE
            LCVRWTQLGA FYPFMRNHNS LLSLPQEPYS FSEPAQQAMR KALTLRYALL PHLYTLFHQA
            HVAGETVARP LFLEFPKDSS TWTVDHQLLW GEALLITPVL QAGKAEVTGY FPLGTWYDLQ
            TVPIEALGSL PPPPAAPREP AIHSEGQWVT LPAPLDTINV HLRAGYIIPL QGPGLTTTES
            RQQPMALAVA LTKGGEARGE LFWDDGESLE VLERGAYTQV IFLARNNTIV NELVRVTSEG
            AGLQLQKVTV LGVATAPQQV LSNGVPVSNF TYSPDTKVLD ICVSLLMGEQ FLVSWC
            (Disulfide bridge:26-53, 36-52, 47-71, 477-502, 591-602, 882-896)
  TYPE      Peptide
REMARK      Therapeutic category: 3959
            ATC code: A16AB22
            Product: D11744<JP/US>
EFFICACY    Enzyme replacement (alpha-glucosidase)
  DISEASE   Pompe disease [DS:H01940]
  TYPE      Enzyme replacement therapy product
COMMENT     Treatment of Pompe disease
TARGET      GAA* [HSA_VAR:2548v1] [HSA:2548] [KO:K12316]
  PATHWAY   hsa00052(2548)  Galactose metabolism
            hsa00500(2548)  Starch and sucrose metabolism
            hsa04142(2548)  Lysosome
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AB Enzymes
                 A16AB22 Avalglucosidase alfa
                  D11744  Avalglucosidase alfa (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Avalglucosidase Alfa
               D11744  Avalglucosidase alfa (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               395  Enzyme preparations
                3959  Others
                 D11744  Avalglucosidase alfa (USAN/INN); Avalglucosidase alfa (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Glycosidases
                GAA* [HSA_VAR:2548v1]
                 D11744  Avalglucosidase alfa (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11744
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11744
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11744
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D11744
DBLINKS     CAS: 1802558-87-7
            PubChem: 405226610
///
